RESTORBIO
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.The Company develops medicines and therapies to treat aging-related diseases and conditions such as cancer, heart disease, neurodegenerative diseases, and diabetes mellitus. resTORbio serves clients in the State of Massachusetts.
RESTORBIO
Industry:
Biopharma Biotechnology Clinical Trials Medical
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.restorbio.com
Total Employee:
11+
Status:
Active
Contact:
617.482.2333
Email Addresses:
[email protected]
Total Funding:
65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Domain Not Resolving
Similar Organizations
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Captura Biopharma
Captura Biopharma is an emerging biotechnology company engaged in the development and commercialization of heavy metal chelators.
Crestone
Crestone is a clinical stage biopharmaceutical company focused on inventing and developing novel mechanism.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Duality Biologics
Duality Biologics is a company focusing on the discovery, development and commercialization of new modality biologics to provide solutions.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Flexus Biosciences
Flexus is a privately-held biopharmaceutical company focused on the creation of novel anti-cancer therapeutics.
GeneMedicine
GeneMedicine is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies.
Liquidia Technologies
Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.
LyGenesis
LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.
Medicure
Medicure is a specialty pharmaceutical Company engaged in the research, clinical development and commercialization of human therapeutics.
OncoCell MDx
OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary.
Oyster Point Pharmaceuticals
Oyster is a clinical stage pharmaceutical company focused on the discovery development & commercialization .
Renovo Concepts
Renovo Concepts focuses on developing and commercializing a new therapeutic modality.
Seelos Therapeutics
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics.
Stealth BioTherapeutics
Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Series A - resTORbio
Recharge Thematic Ventures
Recharge Thematic Ventures investment in Series A - resTORbio
Rock Springs Capital
Rock Springs Capital investment in Series A - resTORbio
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series A - resTORbio
Quan Capital
Quan Capital investment in Series A - resTORbio
Nest.Bio Ventures
Nest.Bio Ventures investment in Series A - resTORbio
PureTech Health
PureTech Health investment in Series A - resTORbio
Official Site Inspections
http://www.restorbio.com Semrush global rank: 472.14 K Semrush visits lastest month: 108.48 K
- Host name: 104.16.150.108
- IP address: 104.16.150.108
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "resTORbio"
resTORbio - Crunchbase Company Profile & Funding
ResTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.See details»
resTORbio Company Profile 2024: Valuation, Investors, …
ResTORbio Inc is a clinical-stage biopharmaceutical company. It mainly focuses on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.See details»
Restore Skin and Hair with Product Comparison
Restorbio.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com. As an Amazon …See details»
ResTORbio Company Profile - Office Locations, Competitors ... - Craft
Sep 18, 2020 · ResTORbio is a company, developing medicines to treat aging-related diseases and conditions. It is focused on developing medicines that address conditions caused by …See details»
Dr. Joan Mannick On Clinical Development For Aging
Jun 14, 2021 · In 2014 ResTORbio spun off out of Novartis and went public to try a longevity drug as a vaccine-potentiating agent in the elderly. The company was led by Dr. Joan Mannick, a physician with deep...See details»
Adicet Announces Completion of Merger with resTORbio - Yahoo …
Adicet will focus on advancing its pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor...See details»
About Restorbio - Restore Skin and Hair with Product Comparison
Grounded in biology and informed by a large body of scientific research, our mission is to review products and their ingredients. Our writers here are huge advocates of their own products and …See details»
Adicet Announces Completion of Merger with resTORbio
Sep 15, 2020 · Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases.See details»
resTORbio - VentureRadar
Website: https://www.restorbio.com/ resTORbio, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to treat aging …See details»
resTORbio Provides Corporate Update and Reports First Quarter …
May 7, 2020 · resTORbio, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to treat aging-related diseases. …See details»
ResTORbio CEO and Key Executive Team | Craft.co
ResTORbio's Co-Founder, President and CEO is Chen Schor. Other executives include Joan Mannick, Co-Founder, Chief Medical Officer; Frederick G. Hayden, Clinical Advisory Board …See details»
Adicet Bio closes merger with resTORbio - S&P Global
Sep 15, 2020 · Post-merger and post-reverse split New York-based Adicet — which is backed by investors including Johnson & Johnson Innovation - JJDC Inc., Novartis Venture Funds and …See details»
PureTech, Novartis create resTORbio | C&EN Global Enterprise
PureTech Health, an R&D and venture investment firm, has licensed two clinical-stage drug programs from Novartis and will create a subsidiary called resTORbio to further develop them. …See details»
Novartis-backed resTORbio raises $40M for aging disease trials
Nov 30, 2017 · RTB101 is one of two orally-active TORC1 (rapamycin complex 1) inhibitors bundled into resTORbio and has been shown to enhance immune function in elderly patients …See details»
resTORbio surges as midstage data set up phase 3 for drug to …
Jul 25, 2018 · Armed with positive phase 2b data, resTORbio is hoping to start pivotal trials next year for its lead drug to prevent respiratory tract infections (RTIs) in the elderly.See details»
Adicet Announces Completion of Merger with resTORbio
Sep 15, 2020 · --Adicet Bio, Inc., a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the completion …See details»
resTORbio Raises $40 Million to Advance Selective TORC1 …
Nov 30, 2017 · BOSTON-- (BUSINESS WIRE)--resTORbio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel …See details»
resTORbio - Leading The Charge Against Aging Related Diseases
Jul 13, 2018 · ResTORbio, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related …See details»
RTB101 and immune function in the elderly: Interpreting an …
Jan 1, 2020 · The biopharmaceutical company resTORbio, Inc. Recently announced termination of a phase 3 clinical trial evaluating the ability of the drug RTB101 to improve immune function …See details»
ResTORbio's Reverse Merger With Adicet Should Unlock …
May 4, 2020 · resTORbio announced a reverse merger with privately held Adicet Bio on April 29 that will result in resTORbio shareholders holding around a 25% stake in the new, publicly …See details»